IL161306A0 - Pharmaceutical formulation comprising (r)-bicalutamide - Google Patents
Pharmaceutical formulation comprising (r)-bicalutamideInfo
- Publication number
- IL161306A0 IL161306A0 IL16130602A IL16130602A IL161306A0 IL 161306 A0 IL161306 A0 IL 161306A0 IL 16130602 A IL16130602 A IL 16130602A IL 16130602 A IL16130602 A IL 16130602A IL 161306 A0 IL161306 A0 IL 161306A0
- Authority
- IL
- Israel
- Prior art keywords
- bicalutamide
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103424A SE0103424D0 (sv) | 2001-10-15 | 2001-10-15 | Pharmaceutical formulation |
| PCT/GB2002/004621 WO2003032950A1 (en) | 2001-10-15 | 2002-10-11 | Pharmaceutical formulation comprising (r) -bicalutamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161306A0 true IL161306A0 (en) | 2004-09-27 |
Family
ID=20285650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16130602A IL161306A0 (en) | 2001-10-15 | 2002-10-11 | Pharmaceutical formulation comprising (r)-bicalutamide |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060058381A1 (ja) |
| EP (1) | EP1439823A1 (ja) |
| JP (1) | JP3639587B2 (ja) |
| KR (1) | KR20050035163A (ja) |
| CN (1) | CN1571658A (ja) |
| AR (1) | AR036877A1 (ja) |
| BR (1) | BR0213248A (ja) |
| CA (1) | CA2462219A1 (ja) |
| CO (1) | CO5580755A2 (ja) |
| HU (1) | HUP0401369A3 (ja) |
| IL (1) | IL161306A0 (ja) |
| IS (1) | IS7219A (ja) |
| MX (1) | MXPA04003520A (ja) |
| NO (1) | NO20041485L (ja) |
| PL (1) | PL368226A1 (ja) |
| RU (1) | RU2004115023A (ja) |
| SE (1) | SE0103424D0 (ja) |
| WO (1) | WO2003032950A1 (ja) |
| ZA (1) | ZA200402729B (ja) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1503662A (zh) * | 2001-02-27 | 2004-06-09 | 药物制剂 | |
| ES2332920T3 (es) | 2004-01-20 | 2010-02-15 | Novartis Ag | Proceso y formulacion de compresion directa. |
| US20080161404A1 (en) * | 2005-02-23 | 2008-07-03 | Astrazeneca Ab | Bicalutamide for Delivering Increasing Steady State Plasma Levels |
| US20080045600A1 (en) * | 2006-08-17 | 2008-02-21 | Gawande Rahul S | Bicalutamide compositions |
| US20100048913A1 (en) | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
| JP2012516900A (ja) | 2009-02-05 | 2012-07-26 | トーカイ ファーマシューティカルズ，インク． | ステロイド性ｃｙｐ１７阻害剤／抗アンドロゲン剤の新しいプロドラッグ |
| CN101987086B (zh) * | 2009-08-03 | 2012-07-18 | 北京化工大学 | 一种超细比卡鲁胺口服片剂及其制备方法 |
| BR112014001440A2 (pt) * | 2011-07-18 | 2017-02-21 | Tokai Pharmaceuticals Inc | novas composições e métodos para o tratamento de câncer de próstata |
| CN105358535B (zh) | 2012-09-11 | 2019-01-04 | 麦迪威森前列腺医疗有限责任公司 | 恩杂鲁胺制剂 |
| SG11201507093WA (en) | 2013-03-14 | 2015-10-29 | Univ Maryland Baltimore Office Of Technology Transfer | Androgen receptor down-regulating agents and uses thereof |
| RU2016104643A (ru) | 2013-08-12 | 2017-09-19 | Токай Фармасьютикалз, Инк. | Биомаркёры для лечения неопластических заболеваний с применением нацеленных на андроген методов лечения |
| MA41107A (fr) * | 2014-12-05 | 2017-10-10 | Aragon Pharmaceuticals Inc | Compositions anti-cancéreuses |
| ES2883187T3 (es) | 2014-12-05 | 2021-12-07 | Aragon Pharmaceuticals Inc | Composiciones anticancerosas |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3629237A (en) * | 1968-09-12 | 1971-12-21 | Shinetsu Chemical Co | Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them |
| US4309405A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| DE3372965D1 (en) * | 1982-07-23 | 1987-09-17 | Ici Plc | Amide derivatives |
| US4946686A (en) * | 1987-09-24 | 1990-08-07 | Merck & Co., Inc. | Solubility modulated drug delivery system |
| ATE159426T1 (de) * | 1991-04-16 | 1997-11-15 | Nippon Shinyaku Co Ltd | Verfahren zur herstellung einer festen dispersion |
| JPH09508125A (ja) * | 1994-01-21 | 1997-08-19 | セプラコー，インコーポレイテッド | 光学的純正ｒ−（−）−カソデックスを使用した男性ホルモン依存疾患治療のための方法と組成 |
| CN1503662A (zh) * | 2001-02-27 | 2004-06-09 | 药物制剂 | |
| MXPA03008999A (es) * | 2001-04-02 | 2004-02-12 | Astrazeneca Ab | Composicion farmaceutica solida que comprende 4-ciano -trifluor-3 -(4-fluorfenilsulfonil) -2-hidroxi-2 -metilpropino -m-toluidida y pvp. |
-
2001
- 2001-10-15 SE SE0103424A patent/SE0103424D0/xx unknown
-
2002
- 2002-10-11 JP JP2003535754A patent/JP3639587B2/ja not_active Expired - Fee Related
- 2002-10-11 KR KR1020047005493A patent/KR20050035163A/ko not_active Application Discontinuation
- 2002-10-11 HU HU0401369A patent/HUP0401369A3/hu unknown
- 2002-10-11 EP EP02770069A patent/EP1439823A1/en not_active Withdrawn
- 2002-10-11 CN CNA028203747A patent/CN1571658A/zh active Pending
- 2002-10-11 MX MXPA04003520A patent/MXPA04003520A/es unknown
- 2002-10-11 US US10/492,629 patent/US20060058381A1/en not_active Abandoned
- 2002-10-11 PL PL02368226A patent/PL368226A1/xx not_active Application Discontinuation
- 2002-10-11 CA CA002462219A patent/CA2462219A1/en not_active Abandoned
- 2002-10-11 WO PCT/GB2002/004621 patent/WO2003032950A1/en active Application Filing
- 2002-10-11 BR BR0213248-6A patent/BR0213248A/pt not_active Application Discontinuation
- 2002-10-11 RU RU2004115023/15A patent/RU2004115023A/ru not_active Application Discontinuation
- 2002-10-11 AR ARP020103826A patent/AR036877A1/es unknown
- 2002-10-11 IL IL16130602A patent/IL161306A0/xx unknown
-
2004
- 2004-04-07 ZA ZA200402729A patent/ZA200402729B/xx unknown
- 2004-04-13 NO NO20041485A patent/NO20041485L/no not_active Application Discontinuation
- 2004-04-14 IS IS7219A patent/IS7219A/is unknown
- 2004-05-12 CO CO04043957A patent/CO5580755A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IS7219A (is) | 2004-04-14 |
| SE0103424D0 (sv) | 2001-10-15 |
| US20060058381A1 (en) | 2006-03-16 |
| WO2003032950A1 (en) | 2003-04-24 |
| EP1439823A1 (en) | 2004-07-28 |
| CO5580755A2 (es) | 2005-11-30 |
| CA2462219A1 (en) | 2003-04-24 |
| ZA200402729B (en) | 2005-01-13 |
| AR036877A1 (es) | 2004-10-13 |
| JP2004521963A (ja) | 2004-07-22 |
| CN1571658A (zh) | 2005-01-26 |
| BR0213248A (pt) | 2004-09-28 |
| NO20041485L (no) | 2004-04-13 |
| KR20050035163A (ko) | 2005-04-15 |
| PL368226A1 (en) | 2005-03-21 |
| RU2004115023A (ru) | 2005-04-10 |
| JP3639587B2 (ja) | 2005-04-20 |
| HUP0401369A2 (hu) | 2004-11-29 |
| MXPA04003520A (es) | 2004-07-23 |
| HUP0401369A3 (en) | 2006-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0102342D0 (en) | Pharmaceutical formulation | |
| GB0319041D0 (en) | Pharmaceutical Formulations | |
| GB0118689D0 (en) | Pharmaceutical formulation | |
| HUP0302847A3 (en) | Pharmaceutical formulation comprising bicalutamide | |
| PL366432A1 (en) | Pharmaceutical formulation | |
| AU2002257582A1 (en) | Pharmaceutical formulation | |
| GB0121715D0 (en) | Pharmaceutical formulations | |
| GB0120701D0 (en) | Pharmaceutical formulations | |
| GB0103638D0 (en) | Pharmaceutical formulations | |
| IL161306A0 (en) | Pharmaceutical formulation comprising (r)-bicalutamide | |
| IL161902A0 (en) | Pharmaceutical formulation comprising bicalutamide | |
| GB2380129B (en) | Pharmaceutical formulations | |
| GB0105560D0 (en) | Pharmaceutical formulations | |
| GB0125492D0 (en) | Formulation | |
| GB0014851D0 (en) | Novel pharmaceutical formulation | |
| GB0124455D0 (en) | Pharmaceutical formulations | |
| GB0104749D0 (en) | Pharmaceutical formulation | |
| GB0014947D0 (en) | Novel pharmaceutical formulation | |
| GB0014892D0 (en) | Novel pharmaceutical formulation | |
| GB0014883D0 (en) | Novel pharmaceutical formulation | |
| GB0116619D0 (en) | Formulation | |
| GB0124712D0 (en) | Pharmaceutical formulation | |
| ZA200402731B (en) | Pharmaceutical formulation. | |
| EP1414417A4 (en) | PHARMACEUTICAL FORMULATION | |
| GB0014869D0 (en) | Novel pharmaceutical formulation |